A.O.U. Pisana

Pisa, Tuscany 56126

0 studies enrolling now · 4 studies all time

What they study most

Atrial Fibrillation, Carcinoma, Transitional Cell, Magnetic Resonance Imaging, Prevention of Stroke or Systemic Embolism, Scleroderma, Systemic

Studies at this site

• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed
• Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose — Completed
• Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis — Completed